Country: Ungverjaland
Tungumál: enska
Heimild: HMA (Heads of Medicines Agencies)
tilmicosin 250 mg/ml
Lavet Pharmaceuticals Ltd.
QJ01FA91
Oral solution
tilmicosin
Cattle Young, Chicken, Pigs, Turkeys
2010-11-24
1 SUMMARY OF PRODUCT CHARACTERISTICS (SPC) 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Tilmicosol _(in Cyprus, Czech Republic, Greece, Hungary, Spain, Lithuania, Portugal and United Kingdom) _ Tilmic _(in Denmark) _ TylmiScan _(in Poland) _ 250 mg/ml Concentrate for Oral Solution for Use in Drinking Water or Milk Replacer 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE: Tilmicosin (as phosphate) 250 mg/ml EXCIPIENTS: Propyl gallate (E 310) 0.2 mg/ml Disodium edetate 2.0 mg/ml For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Concentrate for oral solution for use in drinking water or milk replacer. Clear yellow to amber coloured solution. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Chickens (except hens producing eggs for human comsumption), Turkeys, Pigs, Calves (non ruminant) 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Pigs: For the treatment and prevention of respiratory disease in pig herds, associated with_ _ _Mycoplasma hyopneumoniae, Pasteurella multocida, Actinobacillus pleuropneumoniae _and other organisms susceptible to tilmicosin_. _ 2 Chickens: For the treatment and prevention of respiratory disease in chicken flocks, associated with _Mycoplasma gallisepticum _and_ M. synoviae._ Turkeys: For the treatment and prevention of respiratory disease in turkey locks, associated with _Mycoplasma gallisepticum _and_ M. synoviae._ Calves: For the treatment and prevention of bovine respiratory disease, associated with_ _ _Mannheimia haemolytica, Pasteurella multocida, M Lestu allt skjalið